MYCRONIC AB (1MYCR.MI) Stock Analyst Earnings Estimates
BIT:1MYCR - Euronext Milan - SE0025158629 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.119B 10.44% | 5.706B 11.47% | 7.057B 23.68% | 7.729B 9.52% | 8.192B 5.99% | 8.606B 5.05% | |
| EBITDA YoY % growth | 1.112B -11.54% | 1.515B 36.24% | 2.294B 51.42% | 2.304B 0.44% | 2.503B 8.64% | 2.603B 4.00% | |
| EBIT YoY % growth | 859M -18.35% | 1.251B 45.63% | 2.028B 62.11% | 2.047B 0.94% | 2.228B 8.84% | 2.308B 3.59% | |
| Operating Margin | 16.78% | 21.92% | 28.74% | 26.48% | 27.20% | 26.82% | |
| EPS YoY % growth | 3.80 -10.27% | 5.11 34.47% | 8.62 68.69% | 8.63 0.15% | 12.53 45.15% | 14.78 17.95% |
All data in SEK
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | 1.21 -47.11% | 1.74 -26.15% |
| Revenue Q2Q % growth | 1.557B -12.53% | 1.88B -8.69% |
| EBITDA Q2Q % growth | 386.58M -28.89% | 574.26M 17.78% |
| EBIT Q2Q % growth | 255.34M -53.32% | 380.46M -28.08% |
All data in SEK
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.28 55.10% | 2.31 | -0.03 | -1.09% |
| Q1 2025 Q2Q % growth | 3.18 27.00% | 3.04 | 0.13 | 4.37% |
| Q4 2024 Q2Q % growth | 2.36 -9.94% | 1.58 | 0.77 | 48.96% |
| Q3 2024 Q2Q % growth | 2.30 118.57% | 1.87 | 0.42 | 22.62% |
| Q2 2024 Q2Q % growth | 1.47 114.60% | 1.68 | -0.21 | -12.39% |
| Q1 2024 Q2Q % growth | 2.50 228.95% | 2.20 | 0.30 | 13.73% |
| Q4 2023 Q2Q % growth | 2.62 104.30% | 3.47 | -0.85 | -24.60% |
| Q3 2023 Q2Q % growth | 1.05 34.62% | 0.87 | 0.18 | 21.11% |
| Q2 2023 Q2Q % growth | 0.69 -23.46% | 0.86 | -0.17 | -20.05% |
| Q1 2023 Q2Q % growth | 0.76 -10.06% | 0.83 | -0.07 | -8.58% |
| Q4 2022 Q2Q % growth | 1.28 40.66% | 2.70 | -1.42 | -52.65% |
| Q3 2022 Q2Q % growth | 0.78 90.24% | 0.68 | 0.10 | 14.99% |
| Q2 2022 Q2Q % growth | 0.90 -2.72% | 1.05 | -0.15 | -14.40% |
| Q1 2022 Q2Q % growth | 0.85 -57.64% | 0.92 | -0.08 | -8.46% |
| Q4 2021 Q2Q % growth | 0.91 1.11% | 0.77 | 0.14 | 18.17% |
| Q3 2021 Q2Q % growth | 0.41 -69.74% | 0.82 | -0.41 | -50.07% |
| Q2 2021 Q2Q % growth | 0.92 -15.60% | 0.95 | -0.03 | -3.01% |
| Q1 2021 Q2Q % growth | 2.00 897.50% | 1.54 | 0.45 | 29.24% |
| Q4 2020 Q2Q % growth | 0.90 14.65% | 0.97 | -0.07 | -7.28% |
| Q3 2020 Q2Q % growth | 1.36 78.29% | 1.14 | 0.22 | 18.88% |
| Q2 2020 Q2Q % growth | 1.09 -12.80% | 0.23 | 0.86 | 364.62% |
| Q1 2020 Q2Q % growth | 0.20 -87.50% | 0.03 | 0.17 | 488.12% |
| Q4 2019 Q2Q % growth | 0.79 | 1.02 | -0.23 | -22.85% |
| Q3 2019 Q2Q % growth | 0.76 | 0.51 | 0.25 | 49.77% |
| Q2 2019 Q2Q % growth | 1.25 | 1.14 | 0.11 | 9.42% |
| Q1 2019 Q2Q % growth | 1.60 | 3.05 | -1.45 | -47.58% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.066B 35.30% | 1.931B | 135M | 6.99% |
| Q1 2025 Q2Q % growth | 2.142B 26.60% | 2.11B | 32M | 1.52% |
| Q4 2024 Q2Q % growth | 2.059B 4.62% | 1.826B | 233M | 12.76% |
| Q3 2024 Q2Q % growth | 1.78B 39.72% | 1.608B | 172M | 10.70% |
| Q2 2024 Q2Q % growth | 1.527B 22.65% | 1.594B | -67M | -4.20% |
| Q1 2024 Q2Q % growth | 1.692B 38.80% | 1.693B | -1M | -0.06% |
| Q4 2023 Q2Q % growth | 1.968B 31.46% | 1.827B | 141M | 7.72% |
| Q3 2023 Q2Q % growth | 1.274B 4.94% | 1.31B | -36M | -2.75% |
| Q2 2023 Q2Q % growth | 1.245B -2.20% | 1.355B | -110M | -8.12% |
| Q1 2023 Q2Q % growth | 1.219B 7.40% | 1.264B | -45M | -3.56% |
| Q4 2022 Q2Q % growth | 1.497B 15.69% | 1.602B | -105M | -6.55% |
| Q3 2022 Q2Q % growth | 1.214B 23.12% | 1.182B | 32M | 2.71% |
| Q2 2022 Q2Q % growth | 1.273B 19.64% | 1.311B | -38M | -2.90% |
| Q1 2022 Q2Q % growth | 1.135B -12.08% | 1.266B | -131M | -10.35% |
| Q4 2021 Q2Q % growth | 1.294B 30.31% | 1.198B | 96M | 8.01% |
| Q3 2021 Q2Q % growth | 986M -7.68% | 1.075B | -89M | -8.28% |
| Q2 2021 Q2Q % growth | 1.064B -2.03% | 1.068B | -4M | -0.37% |
| Q1 2021 Q2Q % growth | 1.291B 75.41% | 1.192B | 99M | 8.31% |
| Q4 2020 Q2Q % growth | 993M -15.97% | 1.083B | -90M | -8.31% |
| Q3 2020 Q2Q % growth | 1.068B 18.60% | 1.091B | -23M | -2.11% |
| Q2 2020 Q2Q % growth | 1.086B -3.03% | 846.23M | 239.77M | 28.33% |
| Q1 2020 Q2Q % growth | 736M -33.39% | 685M | 51M | 7.45% |
| Q4 2019 Q2Q % growth | 1.182B | 982.63M | 199.07M | 20.26% |
| Q3 2019 Q2Q % growth | 900.5M | 826.2M | 74.3M | 8.99% |
| Q2 2019 Q2Q % growth | 1.12B | 1.133B | -13.1M | -1.16% |
| Q1 2019 Q2Q % growth | 1.105B | 1.147B | -42M | -3.66% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |